Skip to content

General Practitioner Reassessment of Urinary Infection Antibiotherapy Prescribed by Emergency Departments

General Practitioner Reassessment of the Antibiotherapy of Urinary Infections Initially Treated in Emergency Departments

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03928951
Acronym
ATB-IU
Enrollment
50
Registered
2019-04-26
Start date
2019-06-14
Completion date
2019-09-12
Last updated
2019-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

Urinary infections, Antibiotherapy, Emergency, Reassessment

Brief summary

Urinary infections are at the origin of many emergency department consultations and antibiotic prescriptions. Increase of bacteria resistance to antibiotics is promoted by an inappropriate use of those antibiotics but initial prescription in emergency departments is complicated by brief clinical examinations, unavailable sampling results and risks of multi-resistant bacteria. Large diffusion of new recommendations for urinary infection management should improve the quality of initial antibiotic prescription. However emergency physicians have no knowledge of the reassessment of antibiotherapy 48 to 72 hours after initial prescription by general practitioners which is a quality criterion of good antibiotic use. The main purpose of this study is to estimate the reassessment rate by general practitioners of the urinary infection antibiotherapies prescribed in emergency departments. This will allow assessing the quality of initial antibiotic prescription and help to improve practices.

Detailed description

Urinary infections are at the origin of many emergency department consultations and antibiotic prescriptions. Increase of bacteria resistance to antibiotics is promoted by an inappropriate use of those antibiotics but initial prescription in emergency departments is complicated by brief clinical examinations, unavailable sampling results and risks of multi-resistant bacteria. Large diffusion of new recommendations for urinary infection management should improve the quality of initial antibiotic prescription. However emergency physicians have no knowledge of the reassessment of antibiotherapy 48 to 72 hours after initial prescription by general practitioners which is a quality criterion of good antibiotic use. The main purpose of this study is to estimate the reassessment rate by general practitioners of the urinary infection antibiotherapies prescribed in emergency departments. Patients will be informed during their consultation in one of Toulon - La Seyne sur Mer hospital emergency departments. If they don't express opposition to their data collection, they will be included. A form will then be completed by emergency physicians with initial prescribed antibiotherapy, patients' general practitioners contact information and if patients have a shared medical file or not. 4 to 5 days later, patients' general practitioners will be contacted to know if urinary analysis results were transferred from emergency department to practitioners, if antibiotherapy was modified and if patients' shared medical file was consulted.

Interventions

OTHERGeneral practitioner reassessment of urinary infection antibiotherapy prescribed by emergency departments

Antibiotherapy will be prescribed by emergency physicians and general practitioners will be contacted 4 to 5 days later to know if antibiotherapy was modified

Sponsors

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Every patient more than 18 years who was administered antibiotherapy for urinary infection in emergency department or for whom urinary infection was diagnosed in emergency department (cystitis, acute pyelonephritis, prostatitis)

Exclusion criteria

* Patients less than 18 years old * Patients opposed to their data use * Patients hospitalized more than 24 hours * Patients taking antibiotherapy already before their arrival in emergency department * Patients without sufficient reading capacities or understanding of french language to express opposition to their research participation * Any other reason which, according to investigator, might interfere with research objective evaluation

Design outcomes

Primary

MeasureTime frameDescription
Rate of antibiotherapies modified by general practitioners6 monthsNumber of antibiotic prescriptions modified by general practitioners divided by the total number of initial antibiotic prescriptions

Secondary

MeasureTime frameDescription
Rate of initial antibiotherapies not relevant to recommendations6 monthsNumber of initial antibiotic prescriptions not relevant to recommendations divided by the total number of initial antibiotic prescriptions
Rate of initial antibiotherapies not consistent with recommendations6 monthsNumber of initial antibiotic prescriptions not consistent (molecule, dose, period of time) with recommendations divided by the total number of initial antibiotic prescriptions
Rate of reassessments not relevant to recommendations6 monthsNumber of antibiotic prescription modifications not relevant to recommendations divided by the total number of antibiotic prescription modifications
Rate of reassessments not consistent with recommendations6 monthsNumber of antibiotic prescription modifications not consistent (molecule, dose, period of time) with recommendations divided by the total number of antibiotic prescription modifications
Frequence of use of shared medical file6 monthsNumber of patients for which the shared medical file is used divided by the total number of patients enrolled

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026